Hsp70 ELISA kit, 5/14
May 2014—Enzo Life Sciences now offers the Amp’d HSP70 High Sensitivity ELISA Kit for detecting both baseline and upregulated levels of Hsp70 (Hsp72).
Webinars and Sponsored Roundtables — Register Now
Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.
Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 10, 2026, 1 PM-2 PM ET
Join us for a session to help improve diagnostic accuracy in your practice when scoring HER2 IHC 0 with faint, incomplete membrane staining in ≤10% of tumor cells vs IHC 0 with no membrane staining detected in patients with mBC.
Webinar presenter Jeffrey Gregg, MD, University of Nevada
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.
Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace Directory
Insight Genetics and VICC partnership, 5/14
May 2014—Insight Genetics is collaborating with Vanderbilt-Ingram Cancer Center (VICC) to identify genetic markers that will help select the targeted therapeutics most effective for each triple-negative breast cancer patient.
Data-management software upgrade, 5/14
May 2014—Siemens Healthcare released a software upgrade for the RAPIDComm Data Management System (V5.0), an informatics solution to centrally manage Siemens’ in vitro diagnostics analyzers and operators at the point of care. The upgrade includes the RAPIDComm Web Application, which allows POC coordinators to view the status of their POC instruments and troubleshoot from a handheld device.
FISH upgrades for improved virtual analysis, 5/14
May 2014—Clarient Diagnostic Service, a GE Healthcare company, upgraded its fluorescence in situ hybridization technologies to improve virtual analysis of test results for leukemia, lymphoma, myelodysplastic syndrome, and myeloma.
WaferGen acquisition, 5/14
May 2014—WaferGen Bio-systems acquired the NGS library preparation business from IntegenX. Pursuant to the purchase agreement, the company acquired substantially all of the assets of IntegenX’s product line used in connection with developing, manufacturing, marketing, and selling instruments and reagents relating to library preparation for NGS.
CLSI QMS15 guideline, 5/14
May 2014—The Clinical and Laboratory Standards Institute released a new quality management systems standard: QMS15-A—Laboratory Internal Audit Program; Approved Guideline. The document provides guidance on how a laboratory can establish an internal audit program to enhance the quality of its services through continual improvement. CLSI, 610-688-0100
Hc1.com and Beckman Coulter strategic partnership, 5/14
May 2014—Beckman Coulter Diagnostics and Hc1.com entered a strategic partnership wherein they will combine Beckman Coulter’s clinical diagnostic systems with Hc1.com’s software-as-a-service Healthcare Relationship Cloud.
Hematogenix offers THxID-BRAF, 5/14
May 2014—BioMérieux’s THxID-BRAF companion diagnostic test is now available through Hematogenix Laboratory Services.
Paper on IHC and prostate pathology, 5/14
May 2014—Dako released a paper titled “Immunohistochemistry in Prostate Pathology” that illustrates the significant impact immunohistochemistry can have on diagnostic prostate pathology.
Illumina expands portfolio, 5/14
May 2014—Illumina is making available new products that can be applied directly to the discovery and translation of genomic variation in blood and tissue associated with cancer.